Wearable wrist-watch type cuff oscillometric blood pressure monitors: consensus statement by the European Society of Hypertension Working Group on blood pressure monitoring.
GS, S., A, M., K, A., A, K., G, P., AE, S., J, W., D, A., R, A., & G, B. (2026). Wearable wrist-watch type cuff oscillometric blood pressure monitors: consensus statement by the European Society of Hypertension Working Group on blood pressure monitoring.. Journal of hypertension. https://doi.org/10.1097/HJH.0000000000004415
GS S, A M, K A, A K, G P, AE S, et al. Wearable wrist-watch type cuff oscillometric blood pressure monitors: consensus statement by the European Society of Hypertension Working Group on blood pressure monitoring.. Journal of hypertension. 2026; doi: 10.1097/HJH.0000000000004415
GS S, A M, K A, et al. Wearable wrist-watch type cuff oscillometric blood pressure monitors: consensus statement by the European Society of Hypertension Working Group on blood pressure monitoring.[J]. Journal of hypertension. 2026. DOI: 10.1097/HJH.0000000000004415.
@article{gs2026,
author = {Stergiou GS and Menti A and Asayama K and Kollias A and Parati G and Schutte AE and Wang J and Aristizabal D and Asmar R and Bilo G},
title = {Wearable wrist-watch type cuff oscillometric blood pressure monitors: consensus statement by the European Society of Hypertension Working Group on blood pressure monitoring.},
journal = {Journal of hypertension},
year = {2026},
doi = {10.1097/HJH.0000000000004415},
note = {PMID: 42644439},
}
TY - JOUR AU - Stergiou GS AU - Menti A AU - Asayama K AU - Kollias A AU - Parati G AU - Schutte AE AU - Wang J AU - Aristizabal D AU - Asmar R AU - Bilo G TI - Wearable wrist-watch type cuff oscillometric blood pressure monitors: consensus statement by the European Society of Hypertension Working Group on blood pressure monitoring. T2 - Journal of hypertension PY - 2026 DO - 10.1097/HJH.0000000000004415 AN - PMID:42644439 ER -
Wearable wristwatch-type cuff oscillometric blood pressure (BP) monitors represent a new category of BP devices and are the first wearable monitors to use established cuff-oscillometric BP measurement technology. This consensus statement by the European Society of Hypertension Working Group on BP Monitoring reviews the published evidence on their design, accuracy, validation, clinical application, and remaining research questions. Of 281 articles identified through a systematic PubMed search, 26 were relevant. Several devices are currently available; however, only two have published validation studies performed according to established standards (Omron HeartGuide and Huawei Watch D/D2). Static validation studies generally showed acceptable accuracy, whereas data on 24-h ambulatory use, in special populations, and clinical applications remain limited. Potential advantages include self-initiated measurement at home, at work, and in other settings and conditions; more convenient and repeatable 24-h ambulatory monitoring; more convenient and accurate assessment of asleep BP; capture of stress-related and other BP-related episodes. However, proper wrist position, user adherence, ambulatory performance, and clinical applications require further investigation. More research is needed to establish the accuracy and clinical utility of these novel devices and their role in improving the diagnosis and management of hypertension.